๐Ÿ’Š Antibiotics ยท History ยท Futureโšก June 2026

How Antibiotics Changed the World โ€” And Why We Might Lose Them

From a moldy petri dish in 1928 to 1.27 million deaths from resistant bacteria per year: the complete history of antibiotics, how they work in plain English, and what the resistance crisis means for everything we take for granted in modern medicine.

June 2026 ยท No Infection Consulting & Education
โ† Back to Blog
Published: June 2026
No Infection Consulting & Education
๐Ÿ“Œ Blog Update โ€” June 2026

This article accompanies the No Infection video "How Antibiotics Changed the World โ€” And Why We Might Lose Them," published this week. It is written for a general audience โ€” no prior medical or scientific knowledge required. The article covers the complete arc: discovery, mechanism, impact on human health, the antimicrobial resistance crisis, and the current frontiers of the scientific response. Full bibliography with clickable links at the bottom.

Before 1928, a small cut could kill you. A tooth infection could reach your brain. Having a baby could mean dying from fever a week later. Surgery was so dangerous that many surgeons refused to operate unless the patient was already dying from something else. This is the story of how one contaminated petri dish changed all of that โ€” and why we may be at risk of losing what it gave us.

1928
Fleming discovers penicillin in a contaminated petri dish
1940
Florey & Chain purify penicillin at Oxford โ€” first human treatments
1944
Mass production reaches Allied forces on D-Day
1945
Nobel Prize โ€” Fleming warns of resistance in his acceptance speech
1987
Last new antibiotic class discovered until very recently
2022
Lancet: 1.27M deaths/year directly from antimicrobial resistance

The World Before โ€” Why This Discovery Mattered So Much

It is genuinely difficult, in 2026, to imagine the world that existed before antibiotics. Bacterial infections were everywhere, and they were frequently fatal โ€” not because medicine was primitive in all respects, but because the specific tool needed to fight bacteria did not exist. Surgeons had developed sterile technique, anesthesia had been established, germ theory was understood. And yet, a patient who developed a post-operative wound infection still had no effective treatment beyond the immune system's own resources and supportive care.

Puerperal fever โ€” bacterial infection of the uterus following childbirth โ€” had killed women for centuries. Even after Ignaz Semmelweis demonstrated in the 1840s that handwashing dramatically reduced maternal mortality, and even after the adoption of sterile technique in obstetric practice, infections still occurred and still killed. Pneumonia was described by William Osler as "the captain of the men of death." Bacterial meningitis was nearly universally fatal. Tuberculosis killed an estimated one billion people in the 19th century alone.

A scratch from a rose thorn that became infected could kill a healthy adult through sepsis. A tooth abscess that spread to the jaw could reach the brain. These were not rare events. They were the expected reality of bacterial illness in a world without antibiotics.

~18%
WWI soldier mortality from bacterial pneumonia โ€” with no antibiotics
<1%
WWII soldier mortality from bacterial pneumonia โ€” with penicillin
63โ†’70
US life expectancy 1940 to 1970 โ€” antibiotics a major driver
1.27M
Deaths directly attributed to AMR in 2019 โ€” Lancet 2022

The Discovery โ€” An Accident That Almost Didn't Happen

In September 1928, Alexander Fleming, a bacteriologist at St. Mary's Hospital in London, returned from a holiday to find that one of his petri dishes had been contaminated with a mold โ€” Penicillium notatum. Most researchers would have discarded it. Fleming noticed something unusual: around the mold, there was a clear halo โ€” a zone where the bacteria had died. The mold was producing something that killed them.

He called it penicillin. He published his findings in the British Journal of Experimental Pathology in 1929. And then โ€” almost nothing happened. Fleming could not purify or concentrate the substance in clinically useful quantities. His paper attracted little attention. The discovery sat in the scientific literature for more than a decade.

It took another pair of scientists โ€” Howard Florey and Ernst Chain at Oxford University โ€” to return to Fleming's work in 1939 and develop a method to purify penicillin in sufficient quantities for clinical use. In 1941, they treated their first human patient: Albert Alexander, a policeman dying of a bacterial infection from a scratch on his face. The results were dramatic โ€” he began recovering. The supply of penicillin ran out, and he ultimately died โ€” but the proof of principle was established.

During the Second World War, with the urgent need for a drug that could prevent soldiers from dying of infected wounds, the US government funded the mass production of penicillin at an extraordinary scale. By June 1944, when Allied forces landed on the beaches of Normandy, soldiers had access to penicillin. Bacterial infection โ€” which had killed more soldiers than enemy fire in every previous major war in history โ€” was survivable. In 1945, Fleming, Florey, and Chain shared the Nobel Prize in Physiology or Medicine.

Fleming's Nobel lecture, 1945: In his acceptance speech, Fleming explicitly warned that it would be possible for people to misuse penicillin โ€” by taking doses too small to kill bacteria, creating conditions for resistant organisms to develop and multiply. He said this before the drug was even widely available to the public. He was right. And we did exactly what he warned against.

How Antibiotics Work โ€” In Plain English

An antibiotic is a substance that either kills bacteria directly or stops them from reproducing. Different classes of antibiotics work by targeting different critical structures or processes in bacterial cells. Understanding this โ€” even at a basic level โ€” helps explain both why antibiotics are so effective and why resistance develops.

Antibiotic classWhat it targetsPlain EnglishExamples
Beta-lactamsBacterial cell wall synthesisPrevents bacteria from building the wall that holds them together โ€” they burstPenicillin, amoxicillin, cephalosporins
MacrolidesProtein synthesis (50S ribosome)Shuts down the machinery bacteria use to make proteins they need to surviveAzithromycin, erythromycin
TetracyclinesProtein synthesis (30S ribosome)Blocks a different part of the same protein-making machineryDoxycycline, tetracycline
FluoroquinolonesDNA replicationPrevents bacteria from copying their own DNA โ€” they cannot multiplyCiprofloxacin, levofloxacin
AminoglycosidesProtein synthesis (30S ribosome)Causes bacteria to misread their own genetic code โ€” producing faulty proteinsGentamicin, amikacin
GlycopeptidesCell wall synthesis (different mechanism)Blocks the building blocks of the bacterial cell wall โ€” used when beta-lactams failVancomycin, teicoplanin

The crucial point for non-specialists: antibiotics only work on bacteria. They have no effect whatsoever on viruses. A common cold, influenza, COVID-19, and most sore throats are caused by viruses. Taking an antibiotic for a viral infection does not help the patient recover faster, does not reduce the severity of the illness, and does not prevent complications. But it does expose your gut microbiome to disruption, it can cause side effects, and โ€” most importantly โ€” it contributes to selection pressure for resistant bacteria. This is why the decision of when not to prescribe an antibiotic is as important as the decision of when to prescribe one.

How Antibiotics Transformed Medicine โ€” The Full Picture

The impact of antibiotics on human health was not a single event โ€” it was a cascade of transformations that unfolded over decades and continues to the present. Each one built on the last.

Mortality from infectious disease collapsed. US life expectancy rose from approximately 63 years in 1940 to 70 years by 1970 โ€” a gain of seven years in three decades, with antibiotics and improved vaccination playing major roles. Infant and child mortality from bacterial causes dropped dramatically. Puerperal fever, which had killed mothers for centuries, became treatable. Bacterial meningitis went from near-universally fatal to survivable.

Surgery was transformed. Before antibiotics, surgical infection โ€” wound fever โ€” was a major cause of post-operative death even after the adoption of sterile technique. With prophylactic and therapeutic antibiotics available, surgeons could operate on parts of the body that had previously been too dangerous: the heart, the lungs, joint replacements, transplanted organs. The antibiotic cover that surrounds every elective surgical procedure today is so routine that patients and clinicians alike rarely reflect on its necessity.

Cancer treatment was transformed. Many chemotherapy regimens work by suppressing the immune system as an unavoidable side effect of killing cancer cells. Immunocompromised patients are highly vulnerable to bacterial infections that their immune systems cannot adequately fight. Without antibiotics to manage these infections, modern cancer treatment โ€” as aggressive and effective as it has become โ€” would be far less possible. The same is true for the immunosuppression required to prevent transplant rejection.

Premature care was transformed. Neonatal intensive care medicine is only possible because bacterial infections in premature infants, whose immune systems are immature, can be treated. The extraordinary survival rates of premature babies born at 24, 25, 26 weeks of gestation depend fundamentally on the ability to manage the bacterial infections to which those infants are almost inevitably exposed.

The Golden Age โ€” And Why It Ended

Between 1940 and 1980, scientists discovered more than 20 new classes of antibiotics. Each new class worked through a different mechanism, targeting a different part of bacterial biology, and each was able to treat infections that had developed resistance to earlier drugs. This period โ€” the golden age of antibiotic discovery โ€” gave medicine a toolbox of extraordinary breadth.

After 1980, the rate of new antibiotic class discovery dropped dramatically. Since the approval of daptomycin in 2003, there has been very limited addition of genuinely new antibiotic classes to the clinical toolkit. The reasons are both scientific and economic: finding compounds that are genuinely novel, effective, and safe is extremely hard. And antibiotics โ€” taken for short courses, often curative, with fixed reimbursement โ€” generate less revenue than drugs for chronic conditions taken daily for years. The business model of pharmaceutical development does not align well with the public health imperative of antibiotic innovation.

Antimicrobial Resistance โ€” The Present Crisis

Bacteria reproduce with extraordinary speed โ€” a single organism can produce a billion descendants in 24 hours. In that reproductive torrent, random mutations occur constantly. Most are neutral or harmful to the bacterium. But some, by chance, confer resistance to an antibiotic โ€” the ability to neutralize the drug, pump it out of the cell, or alter the target it binds to. In the presence of an antibiotic, these resistant organisms have an enormous selective advantage: all their non-resistant competitors die, and they survive and multiply.

Every use of an antibiotic โ€” necessary or unnecessary โ€” is a selection event. The more antibiotics are used, the faster resistance develops and spreads. We have accelerated this process in several ways: prescribing antibiotics for viral infections where they are useless, using them as growth promoters in livestock farming on an industrial scale, and making them available over the counter without prescription in many countries.

MRSA
Methicillin-resistant Staphylococcus aureus โ€” once the defining 'superbug.' Now surpassed by more resistant organisms in clinical concern.
CRE
Carbapenem-resistant Enterobacteriaceae โ€” resistant to the 'last resort' antibiotics. Limited treatment options, high mortality.
CRAB
Carbapenem-resistant Acinetobacter baumannii โ€” particularly common in ICUs. Often pan-resistant: no remaining effective antibiotic.
CRKP
Carbapenem-resistant Klebsiella pneumoniae โ€” bloodstream infections with this organism have mortality rates exceeding 50% in some series.
CRPA
Carbapenem-resistant Pseudomonas aeruginosa โ€” major problem in patients with cystic fibrosis and immunocompromised individuals.
VRE
Vancomycin-resistant Enterococcus โ€” resistant to the glycopeptide antibiotic long considered last-line therapy for Gram-positive infections.

The 2022 Lancet study โ€” the most comprehensive global analysis of antimicrobial resistance burden ever conducted โ€” estimated that resistant infections were directly responsible for approximately 1.27 million deaths in 2019, and associated with 4.95 million deaths where resistance played a contributing role. That is more deaths than HIV/AIDS. More than malaria. And the trajectory without intervention is worse: projections have estimated that, by 2050, antimicrobial resistance could account for 10 million deaths per year and represent one of the leading causes of death globally.

"We were given one of the most powerful tools in the history of medicine. And we began using it carelessly before we had finished celebrating."

No Infection Consulting & Education ยท June 2026

What Comes Next โ€” The Frontiers of the Response

๐Ÿ”ฌ
New antibiotics through AI and unconventional sources. After decades of slow progress, artificial intelligence is being applied to antibiotic discovery with genuinely promising early results. In 2020, MIT researchers published a study in Cell demonstrating that a deep learning model identified a compound โ€” halicin โ€” with broad-spectrum antibiotic activity against resistant organisms. AI can screen billions of molecular structures in days rather than years. Simultaneously, researchers are exploring antibiotic candidates from previously unculturable soil bacteria, deep-sea organisms, and the human microbiome.
๐Ÿฆ 
Bacteriophage therapy. Bacteriophages are viruses that infect and kill specific bacteria. They are extraordinarily precise โ€” a phage targeting Klebsiella pneumoniae will not affect Staphylococcus aureusMycobacterium abscessus. The field is advancing rapidly.
๐Ÿ“‹
Antibiotic stewardship. This is the clinical discipline of using antibiotics only when genuinely needed, in the right dose, for the right duration, against the right organism โ€” and not using them when they will not help. Formal stewardship programs in hospitals have been shown to reduce antibiotic consumption by 20 to 30 percent without worsening patient outcomes. Every prescription avoided is selection pressure that does not occur. Stewardship is not dramatic. It is not a new drug. But it works, it is available now, and it matters enormously at scale.
๐Ÿ’‰
Vaccines and infection prevention. A vaccine that prevents a bacterial infection eliminates the need for an antibiotic. Vaccines for pneumococcus, meningococcus, and Haemophilus influenzae have already reduced antibiotic consumption in the populations where they are broadly used. Improved hand hygiene and infection control in healthcare settings slows the horizontal spread of resistant organisms. These are not new technologies. They are proven interventions being applied with variable consistency.

What Every Person Can Do

Fleming's 1945 warning was not addressed to governments or pharmaceutical companies. It was addressed to everyone who would ever take an antibiotic. The choices that determine whether we maintain effective antibiotics are distributed across billions of individual decisions โ€” by patients, physicians, pharmacists, farmers, and policymakers.

Take antibiotics only when a physician determines they are genuinely needed. Complete the full prescribed course โ€” stopping early when you feel better does not save the remaining tablets for later; it creates exactly the conditions for selecting resistant bacteria. Never take antibiotics prescribed for someone else. Never share your prescription. And when a physician tells you that your illness is viral and an antibiotic won't help โ€” trust that advice. It is one of the most important things a clinician can say, and one of the most frequently resisted.

These are not dramatic gestures. They are the ordinary choices that, multiplied across a population, determine whether the antibiotic era continues or begins to end.

๐Ÿ“š Bibliography โ€” Clickable Links
Fleming A. โ€” On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. British Journal of Experimental Pathology, 1929:
doi.org/10.1111/j.1365-2141.1929.tb05244.x
Nobel Prize โ€” Fleming, Florey and Chain: biography, Nobel lecture, and historical context (1945):
nobelprize.org/prizes/medicine/1945/summary
Tan SY, Tatsumura Y. โ€” Alexander Fleming (1881โ€“1955): Discoverer of penicillin. Singapore Medical Journal, 2015:
doi.org/10.11622/smedj.2015105
Murray CJL et al. โ€” Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 2022 (the primary source for 1.27M deaths figure):
doi.org/10.1016/S0140-6736(21)02724-0
WHO โ€” Global action plan on antimicrobial resistance:
who.int/publications/i/item/9789241509763
O'Neill Report โ€” Tackling Drug-Resistant Infections Globally (2016) โ€” the foundational global AMR policy document:
amr-review.org
CDC โ€” 2019 Antibiotic Resistance Threats in the United States:
cdc.gov/antimicrobial-resistance/data-research/threats
Stokes JM et al. โ€” A deep learning approach to antibiotic discovery. Cell, 2020 (halicin discovery via AI):
doi.org/10.1016/j.cell.2020.01.021
Dedrick RM et al. โ€” Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nature Medicine, 2019:
doi.org/10.1038/s41591-019-0437-z
GARDP โ€” Global Antibiotic Research and Development Partnership โ€” current pipeline and policy:
gardp.org
CDC โ€” Core Elements of Hospital Antibiotic Stewardship Programs:
cdc.gov/antibiotic-use/stewardship-report

Stay ahead with physician-led IPC intelligence, outbreak updates, and online certification courses.

View All Courses โ†’